Live Breaking News & Updates on கேய்ட் பெர்மன்|Page 4
Stay updated with breaking news from கேய்ட் பெர்மன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
December 18, 2020 On Thursday in the Southern District of New York, the Securities and Exchange Commission (SEC) filed a complaint against Keith Berman and Decision Diagnostics Corp. (DECN), alleging that the defendants made false and misleading public statements in the spring that they had developed a “break-through” finger-pricking device to test for the novel coronavirus when they actually had not finished the product nor even developed a prototype. In mid-February, Berman, president and CEO of biotechnology company DECN, learned of the location of DECN’s manufacturing site for its glucose testing strip for diabetes and decided to pursue the development of a coronavirus testing kit the first time the company had attempted to create a virus detection test according to the complaint. ....
Decision Diagnostics Corp.: DECN Comments on Recent Legal Filings by Federal Agencies LOS ANGELES, CA / ACCESSWIRE / December 18, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., as well as the designer and manufacturer of the GenViro! Covid-19 Swift Kit testing kits, hereby confirms two recent legal filings by separate agencies of the Federal government regarding DECN and its CEO Keith Berman concerning its GenViro! Covid-19 testing products. Keith Berman, the CEO of DECN, was charged yesterday in Los Angeles by the United States Department of Justice with one count of securities fraud and one count of making a false statement to government officials. It is alleged that Mr. Berman made false and misleading statements in connection with DECN s effort to develop, test and obta ....
DOJ and SEC Pursue Decision Diagnostics CEO on COVID-19 Testing Fraud Posted on 12/19/2020 The U.S. Justice Department revealed that a federal grand jury has indicted a California chief executive for allegedly concocting a scheme to defraud investors with false claims about a COVID-19 test. The false claim led to investor losses. Keith Berman, 67, the CEO of Decision Diagnostics Inc., was charged with one count of securities fraud and one count of making false statements, the DOJ said. The SEC temporarily suspended trading in Decision Diagnostics’ securities on April 23, 2020. The complaint, filed in the U.S. District Court for the Southern District of New York, charges Decision Diagnostics and Berman with violating antifraud provisions of the securities laws ....
DECN Comments on Recent Legal Filings by Federal Agencies albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
DECN EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Decision Diagnostics Corp. – DECN businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.